EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread

Felix Hinz, Dennis Friedel, Andrey Korshunov, Franziska M Ippen, Henri Bogumil, Rouzbeh Banan, Sebastian Brandner, Martin Hasselblatt, Henning B Boldt, Vaidas Dirse, Hildegard Dohmen, Eleonora Aronica und 38 weitere

Acta Neuropathologica · 2025

DOI: 10.1007/s00401-025-02849-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Neuropathologica, 2025. Verfasst von Felix Hinz und 49 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany. Hauptthemen laut MEDLINE: Astrocytoma, Isocitrate Dehydrogenase, Brain Neoplasms, DNA Methylation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Bundesministerium für Bildung und Forschung, Universitätsklinikum Heidelberg.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

IDH-mutant astrocytomas are diffuse gliomas that are defined by characteristic mutations in IDH1 or IDH2 and do not have complete 1p/19q co-deletion. The established grading criteria include histological features of brisk mitotic activity (grade 3) and necrosis and/or microvascular proliferation (grade 4). In addition, homozygous deletion of the CDKN2A/B locus has recently been implemented as a molecular marker for grade 4 IDH-mutant astrocytomas. Here, we describe a subgroup of high-grade IDH -mutant astrocytomas characterised by a primitive neuronal component based on histology and a distinct DNA methylation profile (n = 51, ASTRO PNC). Misinterpretation as carcinoma metastasis was common, since GFAP expression was absent in the primitive neuronal component, whereas TTF-1 expression was detected in 15/19 cases (79%) based on immunohistochemistry. Apart from mutations in IDH1 , TP53 , and ATRX , we observed enrichment for alterations in RB1 (n = 19/51, 37%) and MYCN (n = 14/51, 27%). Homozygous CDKN2A/B deletion (n = 1/51, 2%) and CDK4 amplification (n = 3/51, 6%) were relatively rare events. Clinical (n = 31 patients) and survival data (n = 23 patients) indicate a clinical behaviour similar to other CNS WHO grade 4 IDH-mutant astrocytomas, however with an increased risk for leptomeningeal (n = 7) and extra-axial (n = 2) spread. Taken together, ASTRO PNC is defined by a distinct molecular and histological appearance that can mimic metastatic disease and typically follows an aggressive clinical course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AstrocytomaIsocitrate DehydrogenaseBrain NeoplasmsDNA MethylationMeningeal NeoplasmsHumansFemaleMaleMiddle AgedAdultMutationAgedYoung AdultAdolescentCyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

MYCNRB1AstrocytomaDNA methylationIDH-mutantPrimitive neuronal component

Substanzen

Isocitrate DehydrogenaseIDH1 protein, humanIDH2 protein, humanCyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Neuropathology, Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, 69120, Heidelberg, Germany.
  • Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.
  • Department of Neurology, Heidelberg University Hospital, Heidelberg, Germany.
  • National Center for Tumor Diseases (NCT), NCT Heidelberg, a Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.
  • Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London, UK.

Förderung

  • Deutsche Forschungsgemeinschaft
  • Bundesministerium für Bildung und Forschung
  • Universitätsklinikum Heidelberg

Zitieren

APA

Hinz, F., Friedel, D., Korshunov, A., Ippen, F. M., Bogumil, H., Banan, R., Brandner, S., Hasselblatt, M., Boldt, H. B., Dirse, V., Dohmen, H., Aronica, E., Brodhun, M., Broekman, M. L. D., Capper, D., Cherkezov, A., Deng, M. Y., van Dis, V., Felsberg, J., …, & Suwala, A. K. (2025). IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread. Acta Neuropathologica. https://doi.org/10.1007/s00401-025-02849-8

Vancouver

Hinz F, Friedel D, Korshunov A, Ippen FM, Bogumil H, Banan R, et al. IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread. Acta Neuropathologica. 2025. doi:10.1007/s00401-025-02849-8

BibTeX
@article{Hinz2025,
  author = {Hinz, Felix and Friedel, Dennis and Korshunov, Andrey and Ippen, Franziska M and Bogumil, Henri and Banan, Rouzbeh and Brandner, Sebastian and Hasselblatt, Martin and Boldt, Henning B and Dirse, Vaidas and Dohmen, Hildegard and Aronica, Eleonora and Brodhun, Michael and Broekman, Marike L D and Capper, David and Cherkezov, Asan and Deng, Maximilian Y and van Dis, Vera and Felsberg, Jörg and Frank, Stephan and French, Pim J and Gerlach, Rüdiger and Göbel, Kirsten and Goold, Eric and Hench, Jürgen and Kantelhardt, Sven and Kohlhof-Meinecke, Patricia and Krieg, Sandro and Mawrin, Christian and Morrison, Gillian and Mühlebner, Angelika and Ozduman, Koray and Pfister, Stefan M and Poliani, Pietro Luigi and Prinz, Marco and Reifenberger, Guido and Riemenschneider, Markus J and Sankowski, Roman and Schrimpf, Daniel and Sill, Martin and Snuderl, Matija and Verdijk, Robert M and Voisin, Mathew R and Wesseling, Pieter and Wick, Wolfgang and Reuss, David E and von Deimling, Andreas and Sahm, Felix and Maas, Sybren L N and Suwala, Abigail K},
  title = {IDH-mutant astrocytomas with primitive neuronal component have a distinct methylation profile and a higher risk of leptomeningeal spread},
  journal = {Acta Neuropathologica},
  year = {2025},
  doi = {10.1007/s00401-025-02849-8}
}
Kostenlos starten →